UBS Group’s Defiance Daily Target 2X Long CVNA ETF CVNX Stock Holding History

UBS Group’s Portfolio CVNX Stock Details CVNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$50	Sell	4 -647	-99%	-$12.6K	﹤0.01%	10205
2025 Q4	$17K	Buy	651 +108	+20%	+$2.37K	﹤0.01%	7900
2025 Q3	$13.3K	Buy	+543	New	+$12.4K	﹤0.01%	8403

Other funds holding CVNX

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

UBS Group's CVNX Position: Q1 2026 in Review

UBS Group reduced its Defiance Daily Target 2X Long CVNA ETF (CVNX) stake by 99% in Q1 2026, selling an estimated $12.6K and leaving 4 shares worth $50. The position accounts for ﹤0.01% of the portfolio, ranked #10205.

UBS Group first reported a position in CVNX in Q3 2025 and has held it in 3 quarters since. The position peaked at $17K in Q4 2025. 3 funds tracked by Wall St. Rank hold CVNX as of Q1 2026.

UBS Group held 4 shares of Defiance Daily Target 2X Long CVNA ETF worth $50 as of Q1 2026.
UBS Group sold 647 Defiance Daily Target 2X Long CVNA ETF shares in Q1 2026, an estimated $12.6K.
Defiance Daily Target 2X Long CVNA ETF made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10205 holding.
UBS Group first reported a position in Defiance Daily Target 2X Long CVNA ETF in Q3 2025 and has held it in 3 quarters since.
UBS Group's Defiance Daily Target 2X Long CVNA ETF position peaked at $17K in Q4 2025.
3 funds tracked by Wall St. Rank held Defiance Daily Target 2X Long CVNA ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.